Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes.

NKT cells uniquely remodel the tumor microenvironment, overcome immune resistance, and enable scalable off-the-shelf cell therapy ...

Revolutionary blood testing technology now identifies cancer and Alzheimer's disease before symptoms appear. Advanced genetic science and artificial intelligence extract unprecedented health ...

The FDA already is scheduled to decide by Dec. 30 whether the same drug can be used by patients with hypercortisolism, also ...

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell ...

A new study led by Children's Hospital Los Angeles has found a novel mechanism behind neuroblastoma progression: the shape and structure of the extracellular matrix.

A functional analysis study was conducted on ATM genes that have a high risk of cancer and are closely related to the ...

As of Jan. 1, 2022, there were 187,162 people in the U.S. living with brain and other nervous system tumors, according to the ...

Obesity-related cancer deaths in the U.S. have tripled in just two decades, with women, older adults, and minority groups ...

Cancer deaths linked to obesity have tripled across the United States over the past two decades, according to new research ...

Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post ...

Scientists have discovered that a locally developed cancer drug, PRL3-zumab, may offer a groundbreaking treatment for two ...